Salarius Pharmaceuticals Inc (SLRX)
1.435
0.00 (0.00%)
USD |
NASDAQ |
Sep 27, 16:00
1.42
-0.02
(-1.05%)
After-Hours: 20:00
Salarius Pharmaceuticals Max Drawdown (5Y): 99.98% for Aug. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
August 31, 2024 | 99.98% |
July 31, 2024 | 99.98% |
June 30, 2024 | 99.98% |
May 31, 2024 | 99.98% |
April 30, 2024 | 99.98% |
March 31, 2024 | 99.98% |
February 29, 2024 | 99.98% |
January 31, 2024 | 99.98% |
December 31, 2023 | 99.98% |
November 30, 2023 | 99.98% |
October 31, 2023 | 99.98% |
September 30, 2023 | 99.98% |
August 31, 2023 | 99.98% |
July 31, 2023 | 99.98% |
June 30, 2023 | 99.98% |
May 31, 2023 | 99.98% |
April 30, 2023 | 99.98% |
March 31, 2023 | 99.98% |
February 28, 2023 | 99.98% |
January 31, 2023 | 99.98% |
December 31, 2022 | 99.98% |
November 30, 2022 | 99.96% |
October 31, 2022 | 99.96% |
September 30, 2022 | 99.92% |
August 31, 2022 | 99.92% |
Date | Value |
---|---|
July 31, 2022 | 99.92% |
June 30, 2022 | 99.92% |
May 31, 2022 | 99.92% |
April 30, 2022 | 99.89% |
March 31, 2022 | 99.89% |
February 28, 2022 | 99.89% |
January 31, 2022 | 99.89% |
December 31, 2021 | 99.89% |
November 30, 2021 | 99.89% |
October 31, 2021 | 99.89% |
September 30, 2021 | 99.89% |
August 31, 2021 | 99.89% |
July 31, 2021 | 99.89% |
June 30, 2021 | 99.89% |
May 31, 2021 | 99.89% |
April 30, 2021 | 99.89% |
March 31, 2021 | 99.89% |
February 28, 2021 | 99.89% |
January 31, 2021 | 99.89% |
December 31, 2020 | 99.89% |
November 30, 2020 | 99.89% |
October 31, 2020 | 99.89% |
September 30, 2020 | 99.89% |
August 31, 2020 | 99.89% |
July 31, 2020 | 99.89% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.13%
Minimum
Sep 2019
99.98%
Maximum
Dec 2022
99.88%
Average
99.89%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
Pfizer Inc | 54.78% |
NovaBay Pharmaceuticals Inc | 99.98% |
Palatin Technologies Inc | 96.46% |
iBio Inc | 99.97% |
Theriva Biologics Inc | 99.81% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -90.26 |
Beta (5Y) | 0.9513 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 103.0% |
Historical Sharpe Ratio (5Y) | -0.7506 |
Historical Sortino (5Y) | -1.471 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 47.36% |